Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vella

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Allergy and Clinical Immunology|September 7, 2001
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of ageA Viganò, M Pinti, M Nasi, et al.
HIV Medicine|January 21, 2004
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL)M Floridia, R Bucciardini, V Fragola, et al.
Nature|July 19, 2001
Mission now possible for AIDS fundP Hale, M W Makgoba, M H Merson, et al.
AIDS (London, England)|June 27, 2001
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapineB Conway, M A Wainberg, D Hall, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
Antiviral Research|March 13, 1998
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infectionsM D de Jong, C A Boucher, S A Danner, et al.
Nature|July 19, 2001
Success hinges on support for treatmentP Hale, M W Makgoba, M H Merson, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
AIDS (London, England)|April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol TeamO Pontesilli, E C Guerra, A Ammassari, et al.
AIDS (London, England)|June 21, 2001
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppressionS Grelli, L Di Traglia, C Matteucci, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Allergy and Clinical Immunology|September 7, 2001
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of ageA Viganò, M Pinti, M Nasi, et al.
HIV Medicine|January 21, 2004
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL)M Floridia, R Bucciardini, V Fragola, et al.
Nature|July 19, 2001
Mission now possible for AIDS fundP Hale, M W Makgoba, M H Merson, et al.
AIDS (London, England)|June 27, 2001
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapineB Conway, M A Wainberg, D Hall, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
Antiviral Research|March 13, 1998
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infectionsM D de Jong, C A Boucher, S A Danner, et al.
Nature|July 19, 2001
Success hinges on support for treatmentP Hale, M W Makgoba, M H Merson, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
AIDS (London, England)|April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol TeamO Pontesilli, E C Guerra, A Ammassari, et al.
AIDS (London, England)|June 21, 2001
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppressionS Grelli, L Di Traglia, C Matteucci, et al.
Pageof 18